Simbec-Orion Group is a full-service, boutique CRO which offers specialist expertise in oncology, rare & orphan diseases, dermatology, respiratory, neurology and infectious diseases and translational medicine.
|Number of employees||201-500 employees|
Simbec-Orion Group was created in 2014 by the merger of Simbec Research, the specialist CRO in Early Stage Clinical Development and Orion Clinical, a specialist European Late Stage CRO to create an international, full service, boutique CRO. The Simbec Research Campus is located in South Wales, near Cardiff; this facility houses our 58 bed Clinical Pharmacology Unit, Seirian Laboratories central pathology and bioanalytical laboratories IMP management Team, plus project management, data management and support services.
Orion Clinical has offices in Greater London-UK, Paris-France, Cologne-Germany, Rome-Italy and Princeton-USA, with field based operational personnel across Europe and North America
- A full spectrum of drug development services from first-in-human Phase I clinical studies through to pivotal Phase III studies and Phase IV post marketing studies.
- Specialist expertise in oncology, rare and orphan diseases, respiratory, dermatology and infectious diseases & vaccines
- In-depth experience of all drug types, dosage forms and delivery mechanisms.
- Access to patient populations across Europe and North America.
Top 5 Recent Tweets
|April 07, 2023||EuroPharmaJobs||Senior Clinical Research Associate, Simbec-Orion Group, Home-based, United Kingdom, Deadline 28 April https://t.co/48OejPqzmk|